Cambridge Biotech Corp., bioMerieux Vitek Inc. deal

CBCXE announced that it had filed a reorganization plan with the Bankruptcy Court that includes an agreement to sell its retroviral diagnostics business to bioMerieux for $6.5 million in cash. Under t...